Skip to main content

What the FDA labels say about taking them together

Erythromycin and procainamide

Erythromycin's FDA label of August 1, 2024 names procainamide in its warnings section; the procainamide label PlainMeds reads does not name erythromycin. The erythromycin label: “… clinically significant bradycardia, and in patients receiving Class IA (quinidine, procainamide) or Class III antiarrhythmic agents.”

Check it at the source: the erythromycin FDA label on DailyMed (effective August 1, 2024, Teva Pharmaceuticals USA, Inc.); the procainamide FDA label on DailyMed (effective February 17, 2025, Caplin Steriles Limited).

What does the erythromycin label say about procainamide?

Erythromycin label, warnings

Erythromycin should be avoided in patients with known prolongation of the QT interval, patients with ongoing proarrhythmic conditions such as uncorrected hypokalemia or hypomagnesemia, clinically significant bradycardia, and in patients receiving Class IA (quinidine, procainamide) or Class III (dofetilide, amiodarone, sotalol) antiarrhythmic agents.

Source: FDA drug label (Erythromycin), Teva Pharmaceuticals USA, Inc., effective August 1, 2024 (SPL set 75a0bd5a-d09f-483b-bfd8-f8343b149eb2), via openFDA; the full label on DailyMed

What does the procainamide label say about erythromycin?

Procainamide's label (effective February 17, 2025) does not name erythromycin in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Procainamide Hydrochloride), Caplin Steriles Limited, effective February 17, 2025 (SPL set fcaa5e9a-3c8a-4796-aa87-626268b6cf60), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

38Erythromycin generic labelers
11Procainamide generic labelers
ErythromycinProcainamide
Labeled forBacterial infections, Acnen/a
Boxed warningNoYes
Pharmacy cost (NADAC)$1.96 per tablet 250 mg tabletn/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?